Previous close | 141.49 |
Open | 143.13 |
Bid | 144.70 x 1200 |
Ask | 146.58 x 1200 |
Day's range | 142.35 - 151.29 |
52-week range | 119.71 - 151.73 |
Volume | |
Avg. volume | 270,346 |
Market cap | 9.737B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 30.88 |
EPS (TTM) | 4.75 |
Earnings date | 24 Oct 2024 |
Forward dividend & yield | 1.80 (1.23%) |
Ex-dividend date | 25 Jul 2024 |
1y target est | 158.20 |
AptarGroup ( NYSE:ATR ) Second Quarter 2024 Results Key Financial Results Revenue: US$910.1m (up 1.6% from 2Q 2023...
AptarGroup's (ATR) Q2 top line increases y/y, driven by the strong performance in the Pharma segment.
AptarGroup (ATR) delivered earnings and revenue surprises of 0.74% and 1.66%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?